EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in gut microbiota and thyroid disease: pathogenesis and therapeutics in autoimmune, neoplastic, and nodular conditions

Lihua Fang, Jie Ning

Frontiers in Cellular and Infection Microbiology · 24.12.2024 · 14

DOI: 10.3389/fcimb.2024.1465928 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 24.12.2024. Verfasst von Lihua Fang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Gastrointestinal Microbiome, Probiotics, Thyroid Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review synthesizes key findings from the past five years of experimental literature, elucidating the gut microbiome’s significant influence on the pathogenesis of thyroid diseases. A pronounced shift in the gut microbiota composition has been consistently observed, with a significant reduction in bacteria such as Bifidobacterium , Bacillaceae , Megamonas , and Clostridium , and a notable increase in bacteria, including Bacteroides , Proteobacteria , Actinobacteria , Desulfobacterota , and Klebsiella . These alterations are implicated in the development and progression of thyroid diseases by impacting metabolic pathways including bile acid and cytokine production, including a decrease in short-chain fatty acids (SCFAs) that are crucial for immune regulation and thyroid hormone homeostasis. The review also highlights the therapeutic implications of probiotics in managing thyroid conditions. Evidence suggests that probiotic adjunct therapy can modulate the gut microbiota, leading to improvements in thyroid function and patient outcomes. The use of specific probiotic strains, such as Lactiplantibacillus plantarum 299v and Bifidobacterium longum , has demonstrated potential in enhancing the effects of traditional treatments and possibly restoring a balanced gut microbiota. Notably, fecal microbiota transplantation (FMT) has emerged as a promising intervention in Graves’ Disease (GD), demonstrating the potential to recalibrate the gut microbiota, thereby influencing neurotransmitters and trace elements via the gut-brain and gut-thyroid axes. The integration of microbiome-based therapies with traditional treatments is anticipated to usher in a new era of personalized thyroid disease management, offering a more nuanced approach to patient care. By integrating this body of work, the review offers an innovative perspective on the gut microbiome’s broad impact on thyroid diseases and the therapeutic applications of probiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationGastrointestinal MicrobiomeProbioticsThyroid DiseasesAnimalsHumansBacteriaDysbiosisNeoplasms

Stichwörter der Autor:innen

SCFAscytokinegut microbiotaprobiotics therapythyroid disease

Autor:innen und Institutionen

  • Department of Endocrinology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China.

Zitieren

APA

Fang, L., & Ning, J. (2024). Recent advances in gut microbiota and thyroid disease: pathogenesis and therapeutics in autoimmune, neoplastic, and nodular conditions. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1465928

Vancouver

Fang L, Ning J. Recent advances in gut microbiota and thyroid disease: pathogenesis and therapeutics in autoimmune, neoplastic, and nodular conditions. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1465928

BibTeX
@article{Fang2024,
  author = {Fang, Lihua and Ning, Jie},
  title = {Recent advances in gut microbiota and thyroid disease: pathogenesis and therapeutics in autoimmune, neoplastic, and nodular conditions},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1465928}
}
Kostenlos starten →